Friday, July 20, 2007

UPDATE 1-ImaRx IPO price cut to $5/shr

(Reuters) - According to a July 11 filing with the U.S. Securities and
Exchange Commission, the company was expecting the proposed
maximum price of its IPO to be $7.50 a share.




The Tucson, Arizona-based company expects to use net
proceeds of about $12.3 million from the IPO for product
development, sales and marketing costs, for working capital and
general corporate purposes.


Read more at Reuters.com Bonds News

No comments: